new re intro to health economics. SECTIONS 1: CORE CONCEPTS AND OVERVIEW, SECTION 2:LITTLE TICKET ITEMS SECTIO 3:HIGH COST PROCEDURES

What is the fundamental premise of the economic approach to understanding healthcare?

The fundamental premise is the identification of scarcity as a major cause of many of today's healthcare problems. limited resources are allocated in the healthcare system.

The economic approach involves understanding healthcare issues through an economic lens, focusing on how

limited resources are allocated in the healthcare system.

How is scarcity defined in the context of healthcare economics?

Scarcity is defined as a deficiency in the quantity and/or quality of available goods and services compared with the amounts that people desire. In healthcare, this means there are not enough resources to satisfy everyone's healthcare needs and wants.

What is the "not enough" problem in U.S. healthcare?

The "not enough" problem refers to the approximately 50 million people in the United States who lack health insurance coverage.

Many of these uninsured individuals consequently have difficulty obtaining

adequate care, especially primary care.

The size of the uninsured population has become a

bellwether (leading indicator) of the access problems in the U.S. healthcare system.

define bellwether

leading indicator

What is the "too much" problem in U.S. healthcare?

The "too much" problem refers to the enormous healthcare expenditures in the United States

. In 2010, total expenditures on health care reached over

$2.6 trillion, which was over 7.5% of the Gross National Product (GNP).For comparison, in 1965, healthcare expenditures were only 5.6% of the GNP.

In 2010, total expenditures on health care reached over $2.6 trillion, which was over 7.5% of the Gross National Product (GNP). For comparison, in 1965, healthcare expenditures were only 5.6% of the GNP. This represents a

significant increase in healthcare's share of the economy, raising questions about whether all this spending is necessary and effective.

What is the healthcare paradox described in the introduction?

The healthcare paradox is that the United States faces BOTH:

1. "Not enough" - 50 million uninsured people with difficulty accessing care

2. "Too much" - $2.6 trillion in spending, including services of questionable benefit

the healthcare paradox: not enough v too much highlight the importance of

studying the entire resource allocation process in health care, rather than focusing on just one aspect.

What are the three categories of potentially unnecessary/questionable services identified?

1. "Little ticket" items - Large-volume services like radiographs (X-rays) and lab tests that make up about one-quarter of all hospital costs

2. High-cost procedures - Including coronary artery bypass grafting, transplants, costly intensive care services, and new drugs whose effectiveness is often still undocumented

3. Terminal care services - Hospital services for the terminally ill that consume a disproportionate share of the healthcare dollar

What are "little ticket" items in healthcare, and what percentage of hospital costs do they account for?

Little ticket" items are large-volume services whose impact on health has been questioned. Examples include radiographs (X-rays) and lab tests. They account for approximately one-quarter (25%) of all hospital costs (Angell, 1985).

The term "little ticket" refers to the fact that

each individual service is relatively low-cost, but because they are performed in such massive volumes, their collective cost is enormous

Why are radiographs (X-rays) considered potentially unnecessary in many cases?

Radiographs are considered potentially unnecessary because:

1. Routine overuse - X-rays are often ordered routinely (pre-employment physicals, hospital admissions without respiratory symptoms, annual screening in healthy individuals)

2. Questionable clinical benefit - Many X-rays show incidental benign findings (normal age-related changes, especially in back pain) that lead to unnecessary follow-up testing

3. Radiation exposure concerns - Cumulative radiation from unnecessary X-rays carries small but real cancer risk, especially in children

4. Defensive medicine - Physicians may order X-rays to protect against malpractice claims ("CYA" medicine)

5. The cascade effect - Abnormal incidental findings lead to more testing, patient anxiety, and potential harm

Why are laboratory tests considered potentially unnecessary in many cases?

Laboratory tests are considered potentially unnecessary because:

1. Routine "panels" without clinical indication - Comprehensive metabolic panels, complete blood counts, and liver function tests are often ordered on all patients regardless of condition

2. The cascade effect - Abnormal results on unnecessary tests lead to further testing, specialist referrals, and patient anxiety

3. Poor predictive value - Some lab tests have poor predictive value in certain populations; age-related changes may be mistaken for pathology

4. Excessive re-testing - Tests are repeated more frequently than clinically indicated ("tracking" stable lab values)

5. Economic incentives - Fee-for-service reimbursement rewards more testing; hospital-based labs are profit centers

What is the significance of "little ticket" items accounting for 25% of hospital costs?

This is significant because:

1. It represents a massive portion of hospital spending on services of questionable benefit

2. It suggests substantial potential for cost savings without compromising care quality

3. It indicates systematic overuse of diagnostic testing in hospital settings

4. It highlights the need for evidence-based guidelines for test ordering

5. The aggregate cost of these individually inexpensive tests dwarfs the cost of some high-profile procedures

What is the "cascade effect" in relation to unnecessary testing?

The cascade effect occurs when abnormal results from unnecessary or incidental tests lead to a chain of further testing, procedures, and interventions. For example:

• A slightly elevated liver enzyme on a routine metabolic panel leads to an ultrasound

• The ultrasound shows a benign finding, leading to a specialist referral

• The specialist orders more tests or procedures

This multiplies the cost far beyond the initial test and can cause patient anxiety and potential harm from unnecessary interventions.

How do financial incentives contribute to the overuse of "little ticket" items?

Financial incentives contribute to overuse through:

1. Fee-for-service reimbursement - More services = more revenue; rewards quantity over quality

2. Hospital-based labs and radiology - These are profit centers generating revenue for hospitals

3. In-office testing - Lab testing in physician offices is a profit center

4. No penalty for overuse - Unlike underuse, overuse is not penalized financially

5. High margin on low-cost tests - Many tests have high profit margins, making them attractive to perform in high volume

What high-cost procedures are identified as potentially questionable?

1. Coronary artery bypass grafting (CABG)

2. Transplants

3. Costly intensive care services

4. New drugs with often undocumented effectiveness

Why might coronary artery bypass grafting (CABG) be considered potentially unnecessary?

CABG may be considered potentially unnecessary because:

1. Proper vs. improper use - Clear benefit exists for left main coronary artery disease and severe three-vessel disease, but benefit is questionable for mild single-vessel disease or asymptomatic patients

2. Comparison to medical management - Advances in medications (statins, antiplatelet agents) mean intensive medical therapy may be equally effective for some patients

3. Appropriate use criteria - Studies show 15-25% of cardiac procedures may be for inappropriate indications

4. Geographic variation - Rates vary widely without corresponding outcome variation

5. Procedure risks - Bleeding, infection, stroke, cognitive decline, and graft failure over time

6. Cost considerations - CABG costs $70,000-$150,000 per procedure; when marginal benefit is small, cost-effectiveness is poor

Why might transplants be considered potentially unnecessary in some cases?

Transplants may be considered potentially unnecessary because:

1. Organ scarcity - Organs are uniquely scarce; each transplant means another patient is not transplanted

2. Palliative transplants - In patients with significant comorbidities, expected survival advantage may be small

3. Novel/experimental transplants - Hand, face, and uterus transplants have no life-saving benefit compared to vital organ transplants

4. Long-term complications - Immunosuppression has significant side effects; chronic rejection remains a problem

5. Cost considerations - $300,000-$800,000+ per transplant, plus lifelong follow-up costs

6. Selection criteria - When criteria are broadened, cost-effectiveness declines significantly

Why are intensive care services considered potentially questionable?

ntensive care services may be considered questionable because:

1. Care at end of life - Patients in final six months account for disproportionate costs; many ICU patients are elderly with multiple comorbidities

2. Lack of prognostic precision - Difficulty identifying which patients will benefit

3. Interventions of questionable benefit - Routine ICU monitoring, invasive monitoring, unnecessary ventilator days

4. Family/surrogate decision-making - Difficulty discontinuing treatments ("technological imperative")

5. The futility issue - Interventions that cannot achieve their therapeutic goal

6. Cost and resource use - ICUs consume 20-30% of hospital budgets despite serving a small fraction of patients

Why are new drugs with "often undocumented effectiveness" considered problematic?

New drugs with undocumented effectiveness are problematic because:

1. Accelerated approval pathways - Many approved based on surrogate endpoints (e.g., tumor shrinkage) that don't predict improved survival or quality of life

2. Limited evidence at approval - Phase III trials may be short-term and in highly selected populations

3. Off-label use without evidence - Prescribed for conditions not in FDA label without supporting evidence

4. Very high costs with modest benefits - Cancer drugs costing $100,000+/year with survival benefit measured in months

5. Marketing and promotion - Direct-to-consumer advertising creates demand; marketing influences prescribing

6. Examples - Avastin for breast cancer (approved then withdrawn), Aduhelm for Alzheimer's (controversial approval)